血管内皮生长因子及其受体在肝癌研究中的进展
被引量:1
出处
《检验医学与临床》
CAS
2006年第7期310-312,共3页
Laboratory Medicine and Clinic
基金
河北省科学技术发展和规划项目(批准文号:052761288)
参考文献11
-
1侯振江,张宗英.血管内皮生长因子及其受体检测在恶性肿瘤诊疗中的应用[J].诊断学理论与实践,2005,4(1):86-88. 被引量:18
-
2[2]Veikkola T,Karkkainen M,Claesson-Melsh L,et al.Regulation of angiogenesis via vascular endothelial growth factor receptor[J].Cancer Res,2000,60 (2):202-212.
-
3[3]Migdal M,Huppertz B,Tessler S,et al.Neuropilin-1 is a placenta growth factor-2 receptor[J].J Biol Chem,1998,273(35):2272-2278.
-
4王业忠,刘祺,彭心宇.血管内皮生长因子及其受体与脑肿瘤的关系[J].实用肿瘤学杂志,2003,17(4):318-320. 被引量:4
-
5[5]An FQ,Matsuda M,Yujii H,et al.Expression of vascular endothelial growth factor in surgical specimens of hepatoellular carcinoma[J].J Cancer Res Clin Oncol,2000,126 (3):153-156.
-
6赵文和.影响肝细胞癌预后的若干生物学因素[J].实用肿瘤杂志,1999,14(2):124-126. 被引量:2
-
7[7]Poon RT,Neng LO,Lau C,et al.Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma:a prospective study[J].Ann Surg,2001,233(2):227-235.
-
8张义,邹雄,王传新.肝细胞癌患者外周血中血管内皮生长因子的表达及其临床意义[J].实用癌症杂志,2003,18(6):571-572. 被引量:2
-
9[9]Baek JH,Jang JE,Kang CM,et al.Hypoxia-induced VEGF enhances tumor survivability via suppression of serum deprivation-induced apoptosis[J].Oncogene,2000,19 (40):4621-4628.
-
10[10]Ishigami SI,Arii S,Furutani M.Predictive value of vascular endothelial growth factor(VEGF) in metastasis and prognosis of human colorect cancer[J].Br J Cancer,1998,78(10):1379-1384.
二级参考文献47
-
1赵文和,冯懿正,丁伟,周水云.小肝癌DNA含量分析[J].实用肿瘤杂志,1996,11(3):110-112. 被引量:2
-
2孙兮文 王嵩 沈天真 等.慕上胶质瘤瘤周水肿的MRI研究[J].实用放射学杂志,2002,14(1):5-7.
-
3[1]Migdal M, Huppertz B, Tessler S, et al. Neuropilin-1 is a placenta growth factor- 2 receptor[J]. J Biol Chem, 1998,273(35):22272-22278.
-
4[2]Takanami I, Tanaka F, Hashizume T, et al. Vascular endothelial growth factor and its receptor correlate with angiogenesis and survival in pulmonary adenocarcinoma[J].Anti cancer Res, 1997,17(4A):2811-2814.
-
5[4]Yonemura Y, Fushida S, Bando E, et al. Lymphangiogenesis and the vascular endothelial growth factor receptor (VEGFR)-3 in gastric cancer[J]. Eur J Cancer, 2001,37(7):918-923.
-
6[9]Tang RF, Itakura J, Aikawa T, et al. Overexpression of lymphangiogenie growth factor VEGF-C in human pancreatic cancer[J]. Pancreas, 2001,22(3):285-292.
-
7[11]Latil A, Bieche I, Pesche S, et al. VEGF overexpression in clinically localized prostate tumors and neuropilin-1 overexpression in metastatic forms[J]. Int J Cancer, 2000,89(2):167-171.
-
8[12]Hazelton D, Nicosia RF, Nicosia SV. VEGF levels in ovarian cyst fluid correlate with malignancy[J]. Clin Cancer Res, 1999,5(4):823-829.
-
9[13]Gadducci A, Ferdeghini M, Fanucchi A, et al. Serum preoperative VEGF in epithelial ovarian cancer relationship prognostic variables and clinical outcome [J]. Anticancer Res, 1999,19(2B):1401-1405.
-
10[14]Giatromanolaki A, Sivridis E, Brekken R, et al. The angiogenic "vascular endothelial growth factor/flk-1 (KDR)receptor"pathway in patients with endometrial carcinoma [J]. Cancer, 2001,92(10):2569-2577.
共引文献20
-
1马振增,燕善军.原发性肝癌患者介入治疗前后血清胰岛素样生长因子Ⅰ、血管内生长因子和甲胎蛋白的变化[J].实用医学杂志,2009,25(5):720-722. 被引量:2
-
2王伟,王茂德.碱性成纤维细胞生长因子在胶质瘤发生、发展和治疗中的意义[J].现代肿瘤医学,2006,14(3):368-370.
-
3周哲,谷小虎.原发胃癌中VEGF检测与临床病理因素的相关性研究[J].实用肿瘤学杂志,2006,20(2):103-105. 被引量:15
-
4安国瑞,侯振江.血管内皮生长因子及其受体在肺癌诊疗中的应用[J].中国肿瘤临床与康复,2006,13(4):373-375. 被引量:5
-
5侯振江,王秀文,张丽华,周秀艳,戴殿禄,闫金辉.原发性肝癌患者血清血管内皮生长因子和甲胎蛋白的表达及临床意义[J].国际检验医学杂志,2006,27(11):964-966. 被引量:7
-
6侯振江,王秀文,张丽华,周秀艳,戴殿禄,闫金辉.原发性肝癌患者血清leptin,VEGF和AFP表达的意义[J].世界华人消化杂志,2006,14(33):3195-3200. 被引量:18
-
7牟兆新,侯振江.血管内皮生长因子及其受体在胃癌研究中的进展[J].现代预防医学,2006,33(12):2330-2331. 被引量:3
-
8侯振江,王秀文,张丽华,周秀艳,戴永路,阎金辉.原发性肝癌患者血清VEGF和AFP检测及其相关性分析[J].现代预防医学,2007,34(5):975-977. 被引量:6
-
9侯振江,周秀艳,王秀文,张丽华.肝细胞癌患者血清VEGF水平检测及与临床分期的相关分析[J].中国老年学杂志,2007,27(11):1050-1051. 被引量:1
-
10师阳,李彬,常乐.肝细胞癌患者血清血管内皮细胞生长因子和基质金属蛋白酶-9的水平变化及其意义[J].实用诊断与治疗杂志,2008,22(4):255-257. 被引量:3
同被引文献8
-
1侯振江,张宗英.血管内皮生长因子及其受体检测在恶性肿瘤诊疗中的应用[J].诊断学理论与实践,2005,4(1):86-88. 被引量:18
-
2黑振宇,王鲁,金惠铭.VEGF与原发性肝癌血管新生关系的研究进展[J].中国微循环,2005,9(4):292-294. 被引量:11
-
3李兴睿,廖晓锋,易继林.VEGF在肝癌经肝动脉栓塞化疗术后的表达及临床意义[J].中国现代医学杂志,2005,15(17):2647-2649. 被引量:7
-
4侯振江,王秀文,张丽华,周秀艳,戴殿禄,闫金辉.原发性肝癌患者血清leptin,VEGF和AFP表达的意义[J].世界华人消化杂志,2006,14(33):3195-3200. 被引量:18
-
5Torimura T,Sata M,Uena T,et al.Increased expression of vascular endothelial growth factor is associated with tumor progression in hepatocellular carcinoma[J].Hum Pathol,1998;29(9):986-91.
-
6Karayiannakis AJ,Syrgos KN,Zbar A,et al.Clinical significance of preoperative serum vascular endothelial growth factor levels in patients with colorectal cancer and the effect of tumor surgery[J].Surgery,2002;131(5):548-55.
-
7Poon RT,Ng IO,Lau C,et al.Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma:a prospective study[J].Ann Surg,2001;233(2):227-35.
-
8梁军,于丽,沈方臻.肝癌中血管生成VEGF及其受体水平与预后的关系[J].中国肿瘤临床,2004,31(4):197-200. 被引量:23
-
1沈秀华,江悦琴.血管内皮生长因子及其受体与肿瘤关系的研究进展[J].临床与实验病理学杂志,1999,15(1):60-61. 被引量:12
-
2刘红,王文奇,刘倩.血管内皮生长因子与胃癌的关系[J].山东医药,2002,42(22):64-65.
-
3张秀琴,吕喜英,胡建功.抑癌基因P53和血管内皮生长因子在非小细胞肺癌中的表达及临床意义[J].临床荟萃,2005,20(12):683-685.
-
4郑玉军,张洋.血管内皮生长因子在肿瘤患者血清及渗出液中的表达[J].中国肿瘤临床与康复,2005,12(1):91-93.
-
5马莹.血管内皮生长因子及其与肺癌关系的研究进展[J].中国肺癌杂志,2001,4(4):318-320.
-
6侯振江,张风巧.端粒酶检测在妇科恶性肿瘤诊疗中的应用[J].国外医学(临床生物化学与检验学分册),2003,24(6):356-357. 被引量:4
-
7侯振江,张凤巧.端粒酶检测在妇科恶性肿瘤诊疗中的应用[J].中国实验诊断学,2002,6(5):307-308.
-
8柴琳,张洪福.血管内皮生长因子与头颈部肿瘤的关系[J].皖南医学院学报,2003,22(4):313-315.
-
9侯振江,张宗英,赵勇.糖蛋白检查在胰腺癌诊疗中的应用[J].中华腹部疾病杂志,2001,1(4):356-358. 被引量:1
-
10李桂林,曲元明.血管内皮生长因子与人脑胶质瘤[J].中国微侵袭神经外科杂志,1998,3(4):297-299.